elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Communities
Institutions
beta
Research Intelligence
Lab
API & MCP
Pricing
Log in
Sign up
Home
/
Subjects
/
Atezolizumab
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Atezolizumab
RIS
0.002
(Research Intensity Score)
Papers
229
Top papers
Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial
2021 · 1497 citations
Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer
2026 · 113 citations
Small Cell Lung Cancer
2025 · 158 citations
Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLC
2020 · 1736 citations
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial
2023 · 237 citations
Newest papers
Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer
2026 · 113 citations
Chemoradiation ± Atezolizumab in Limited-Stage Small Cell Lung Cancer: Results of NRG Oncology/Alliance LU005
2026 · 23 citations
Model‐Based Meta‐Analysis of Overall Survival in Vulnerable Platinum‐Ineligible NSCLC Populations
2026 · 3 citations
Emerging therapies and translational advances in small cell lung cancer: Overcoming resistance
2026 · 2 citations
Small Cell Lung Cancer
2025 · 158 citations
A sample from the 100 top papers behind Atezolizumab.
Create a free account to browse them all →
Atezolizumab's history
Research intensity over time
Explore Atezolizumab's full history
Hover any year for its value and switch resolutions with a free account. Personal adds monthly detail and the historical-intensity (HRI) line.
Create a free account
Already have an account?
Log in
to explore the data.
Close ✕
Atezolizumab's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link